⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 31, 2024Journal of Bone MetabolismOpen Access

Two-Year Outcomes of Daily and Twice-Weekly Teriparatide Treatment in Postmenopausal Women with Severe Osteoporosis: A Randomized Non-Blinded Prospective Study

Takeshi Mochizuki Koichiro Yano Katsunori Ikari Ken Okazaki

View Full Paper

Ask AI

Bookmark

Share

Abstract

The long-term effects of daily teriparatide (D-TPTD) and twice-weekly TPTD (W-TPTD) injections are compared among postmenopausal women with severe osteoporosis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mochizuki et al. (2024) studied this question.

synapsesocial.com/papers/68e6775fb6db643587601745 https://doi.org/10.11005/jbm.2024.31.2.162

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical outcomes of twice-weekly teriparatide acetate administration in osteoporosis2025
2The effects of sequential therapy using anti-resorptive agents after administering once-weekly teriparatide or twice-weekly teriparatideHuman Clinical Trial · 2026
3Randomized crossover comparison of two teriparatide self-injection regimens for primary osteoporosis: final report of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06)2025 · 1 citations
4A crossover comparison of patient satisfaction with two teriparatide regimens: primary results of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06)2024 · 3 citations
5Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label TrialRCT · 2022 · 3 citations